(Q408163)

English

anagrelide

chemical compound

Agrylin®
BL-4162a
Xagrid®
Anagrelide
Anagrelida
Anagrelidum

In more languages

Statements

type of chemical entity

0 references

chemical compound

0 references

0 references

chemical structure

Anagrelide.svg
512 × 258; 11 KB

0 references

254.996617 dalton

1 reference

language of work or name

anagrelide (English)

3 October 2016

chemical formula

C₁₀H₇Cl₂N₃O

1 reference

language of work or name

anagrelide (English)

20 November 2016

canonical SMILES

C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31

1 reference

language of work or name

anagrelide (English)

20 November 2016

active ingredient in

1 reference

14 February 2018

World Health Organisation international non-proprietary name

anagrelide (English)

1 reference

language of work or name

anagrelide (English)

3 October 2016

medical condition treated

thrombocytopenia

1 reference

language of work or name

13 December 2016

polycythemia vera

1 reference

language of work or name

13 December 2016

myeloproliferative disorders

1 reference

language of work or name

13 December 2016

essential thrombocytosis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

14 March 1997

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/K9X45X0051

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb960074-99c1-4a73-941f-f0644a7ec219

significant drug interaction

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

arsenic trioxide

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-citalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Phosphodiesterase 3A

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

pregnancy category

Australian pregnancy category B3

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E*

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Anagrelide

5 July 2017

subject has role

phosphodiesterase inhibitors

1 reference

5 March 2018

fibrinolytic agents

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

platelet aggregation inhibitors

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

Commons category

Anagrelide

0 references

Identifiers

InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)

1 reference

language of work or name

anagrelide (English)

20 November 2016

OTBXOEAOVRKTNQ-UHFFFAOYSA-N

2 references

language of work or name

anagrelide (English)

20 November 2016

ChEBI release 2020-09-01

CAS Registry Number

2 references

Global Substance Registration System

language of work or name

anagrelide (English)

20 November 2016

OTBXOEAOVRKTNQ-UHFFFAOYSA-N

CAS Common Chemistry

8 April 2021

https://commonchemistry.cas.org/detail?cas_rn=68475-42-3

1 reference

language of work or name

Anagrelide (English)

20 November 2016

1 reference

language of work or name

anagrelide (English)

20 November 2016

1 reference

matched by identifier from

OTBXOEAOVRKTNQ-UHFFFAOYSA-N

Reaxys registry number

619582

1 reference

language of work or name

anagrelide (English)

3 October 2016

mapping relation type

2 references

language of work or name

ANAGRELIDE (English)

20 November 2016

matched by identifier from

International Chemical Identifier

InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)

1 reference

language of work or name

ANAGRELIDE (English)

20 November 2016

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

OTBXOEAOVRKTNQ-UHFFFAOYSA-N

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

OTBXOEAOVRKTNQ-UHFFFAOYSA-N

1 reference

Hazardous Substances Data Bank

publication date

28 October 2019

ANAGRELIDE (English)

10 May 2021

DSSTox substance ID

0 references

DSSTOX compound identifier

0 references

0 references

ECHA Substance Infocard ID

0 references

1 reference

language of work or name

Anagrelide (English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

anagrelide (English)

20 November 2016

MeSH descriptor ID

1 reference

Medical Subject Headings

MeSH descriptor ID

14 March 2018

1 reference

Global Substance Registration System

language of work or name

anagrelide (English)

20 November 2016

1 reference

matched by identifier from

OTBXOEAOVRKTNQ-UHFFFAOYSA-N

Human Metabolome Database ID

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

OTBXOEAOVRKTNQ-UHFFFAOYSA-N

2 references

Global Substance Registration System

language of work or name

anagrelide (English)

20 November 2016

matched by identifier from

OTBXOEAOVRKTNQ-UHFFFAOYSA-N

MedlinePlus drug identifier

0 references

1 reference

Global Substance Registration System

language of work or name

anagrelide (English)

20 November 2016

Probes And Drugs ID

0 references

1 reference

language of work or name

anagrelide (English)

3 October 2016

1 reference

Freebase Data Dumps

publication date

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

Römpp online ID

1 reference

imported from Wikimedia project

German Wikipedia

1 reference

Global Substance Registration System

language of work or name

anagrelide (English)

20 November 2016

1 reference

based on heuristic

inferred by common MeSH mappings on source and on Wikidata

25 May 2023

WikiProjectMed ID

0 references

Sitelinks

Wikipedia(17 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswiki Category:Anagrelide

Retrieved from "https://www.wikidata.org/w/index.php?title=Q408163&oldid=2186675750"